Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Type 2 diabetes mellitus Age: Adult |
Dose: Oral Tablet – 30 mg/2 mg or 30 mg/4 mg Frequency: once daily Note: Initially 1 tablet, then titrate gradually as needed. |
|
Indication: Type 2 diabetes mellitus Age: Elderly |
Dose: Oral Tablet – glimepiride 1 mg/day Note: Should start with glimepiride 1 mg/day prior to initiating pioglitazone + glimepiride combination. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved dosage – N/A Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Type 2 Diabetes Mellitus Condition: Renal Impairment CrCl less than 22 mL/min |
Dose: Tablet – 1 mg glimepiride by mouth (oral) Frequency: once daily Note: prior to initiating glimepiride/pioglitazone; titrate conservatively to avoid hypoglycemia; base dose titration on fasting glucose levels |
|
Indication: Type 2 Diabetes Mellitus Condition: Renal Impairment CrCl greater than 22 mL/min |
Dose: Tablet – 30 mg/2 mg or 30 mg/4 mg by mouth (oral) Frequency: once daily Note: initially; base dose titration on fasting glucose levels |
Administration
- Take with first main meal
- Regular schedule
Side Effect
- Peripheral edema (6-12%)
- Upper respiratory tract infection (URTI) (12-15%)
- Weight gain (9-13%)
- Hypoglycemia (13-16%)
- Anemia (Less than 2%)
- Limb pain (4-5%)
- Urinary Tract Infection (UTI) (6-7%)
- Headache (4-7%)
- Diarrhea (4-6%)
- Nausea (4-5%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP2C8 inhibitors (e.g. gemfibrozil), CYP2C9 inhibitors (e.g. fluconazole)
|
Increased plasma levels
|
|
CYP2C8 inducers (e.g. rifampicin)
|
Decreased plasma levels
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Established CHF (NYHA Class III Or IV)
|
Can worsen heart failure
|
|
Type 1 DM Or Diabetic Ketoacidosis
|
Ineffective and dangerous
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place. Protect from light and moisture. Keep out of the reach of the children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.